Back to results
US 2009/0291950 A1Published application
Bicyclic heteroaryl inhibitors of pde4
AssigneeKalypsys, Inc.
InventorsSteven P. Govek, Andrew K. Shiau, Stewart A. Noble, David J. Thomas
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Claims19
A compound of structural Formula II
- or a salt, ester, or prodrug thereof, wherein:
- X1 is selected from the group consisting of O, N(R14) and (CR15R16);
- X2 is selected from the group consisting of (CR18R19), COR18, and null;
- X is selected from the group consisting of N(R17) and (CR20R21);
- R1 and R2 are independently selected from the group consisting of —(CH2)sG1G2G3, acyl, acylalkyl, carboxyalkyl, cyanoalkyl, alkoxy, alkoxyalkyl, amidoalkyl, amino, alkyl, alkylalkoxy, aminoalkyl, alkenyl, alkynyl, carboxyl, carboxyalkyl, ether, heteroalkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, heterocycloalkylalkyl, aralkyl, aryl, guanidine, heteroaryl, heteroaralkyl, hydrogen and hydroxyalkyl, any of which may be optionally substituted;
- s is 1-8;
- G1 is selected from the group consisting of alkoxy, amino, amido, carbonyl, hydroxy, ether, an amino acid, and null;
- G2 is selected from the group consisting of alkyl, alkoxy, amino, aryl, halo, haloalkyl, heterocycloalkyl, heteroaryl, carboxylalkylamino, guanidine, an amino acid, and null, any of which may be optionally substituted;
- G3 is selected from the group consisting of alkyl, alkoxy, amino, hydroxy, ether, carboxyl, hydroxamic acid, an amino acid, phosphonate, phosphoamide, and null, any of which may be optionally substituted;
- R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, alkoxy and lower alkyl;
- R5 is selected from the group consisting of —(CR8R9)mW(CR10R11)n— and —(CR12R13)p—;
- W is selected from the group consisting of O, N(R7), C(O)N(R7), and SOq;
- m, n, and q are independently 0, 1 or 2;
- p is 1 or 2;
- R6 is selected from the group consisting of carboxyl, alkylcarboxy, amido, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, alkyl, heteroalkyl, acyl, and hydroxamic acid, any of which may be optionally substituted;
- R7, R8, R9, R10, R11, R12, and R13 are independently selected from the group consisting of hydrogen and optionally substituted lower alkyl;
- R14 and R17 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, lower alkyl, hydroxyalkyl, haloalkyl, aminoalkyl, and a bond;
- R15, R16, R19, R20, and R21 are independently selected from the group consisting of hydrogen, halogen, lower alkyl, haloalkyl, hydroxyalkyl, heterocycloalkylalkyl, alkoxy, haloalkoxy, amino, aminoalkyl, aminoalkoxy and a bond;
- and
- R18 is selected from the group consisting of halogen, lower alkyl, haloalkyl, hydroxyalkyl, heterocycloalkylalkyl, alkoxy, haloalkoxy, amino, aminoalkyl, aminoalkoxy and a bond.
17 more elements
A compound selected from the group consisting of Examples 1 to 30.
Dependencies are inferred from the claim text.